Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
作者： John Kuriyan , John Kuriyan , Bayard Clarkson , David Wisniewski , Bhushan Nagar
DOI:
关键词:
摘要: … with imatinib to inhibit Bcr-Abl-… Bcr-Abl resemble those detected during c-kit signal transduction (57), we set out to dissect src family kinase-dependent target phosphorylation in the c-kit …
aacrjournals.org
researchgate.net 参考文章(68)
Philipp le Coutre, Elena Tassi, Marileila Varella-Garcia, Rossella Barni, Luca Mologni, Gonçalo Cabrita, Edoardo Marchesi, Rosanna Supino, Carlo Gambacorti-Passerini, Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood. ,vol. 95, pp. 1758- 1766 ,(2000) , 10.1182/BLOOD.V95.5.1758.005A41_1758_1766
Maria Debiec-Rychter, Jerzy Lasota, Maarit Sarlomo-Rikala, Radzislaw Kordek, Markku Miettinen, Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. Cancer Genetics and Cytogenetics. ,vol. 128, pp. 24- 30 ,(2001) , 10.1016/S0165-4608(01)00395-8
Clarkson B, Wisniewski D, Berman E, Strife A, c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Leukemia. ,vol. 10, pp. 229- 237 ,(1996)
Robert A. Weinberg, Oncogenes and the molecular origins of cancer Cold Spring Harbor Laboratory Press. ,(1989)
J ten Hoeve, RB Arlinghaus, JQ Guo, N Heisterkamp, J Groffen, TYROSINE PHOSPHORYLATION OF CRKL IN PHILADELPHIA+ LEUKEMIA Blood. ,vol. 84, pp. 1731- 1736 ,(1994) , 10.1182/BLOOD.V84.6.1731.1731
François Xavier Mahon, Michael W. N. Deininger, Beate Schultheis, Jérome Chabrol, Josy Reiffers, John M. Goldman, Junia V. Melo, Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance Blood. ,vol. 96, pp. 1070- 1079 ,(2000) , 10.1182/BLOOD.V96.3.1070
Brian J. Druker, Elisabeth Buchdunger, Thomas Meyer, Marcel Müller, Nicholas B. Lydon, Helmut Mett, Jürg Zimmermann, Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative Cancer Research. ,vol. 56, pp. 100- 104 ,(1996)
Mary Srethapakdi, Mark M. Moasser, Neal Rosen, Komal S. Sachar, Alan J. Kraker, Inhibition of Src Kinases by a Selective Tyrosine Kinase Inhibitor Causes Mitotic Arrest Cancer Research. ,vol. 59, pp. 6145- 6152 ,(1999)
C Sirard, P Laneuville, JE Dick, Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism Blood. ,vol. 83, pp. 1575- 1585 ,(1994) , 10.1182/BLOOD.V83.6.1575.1575
Warren S. Pear, Juli P. Miller, Lanwei Xu, John C. Pui, Benny Soffer, Robert C. Quackenbush, Ann Marie Pendergast, Roderick Bronson, Jon C. Aster, Martin L. Scott, David Baltimore, Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow Blood. ,vol. 92, pp. 3780- 3792 ,(1998) , 10.1182/BLOOD.V92.10.3780